[Pulmonary embolism: the Pulmonary Embolism Severity Index (PESI) score and mortality predictors].

Embolie pulmonaire: indice de sévérité de l’embolie pulmonaire (ISEP) score et facteurs prédictifs de mortalité.

Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2023
Historique:
received: 22 01 2023
accepted: 25 02 2023
medline: 15 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

pulmonary embolism is a real public health problem because of its high morbidity and mortality rate. The purpose of this study is to evaluate the impact of PESI score on the prognosis of pulmonary embolism. we conducted a retrospective study of 146 cases of formally confirmed embolism. Pulmonary embolism severity index (PESI) score was calculated for the entire study population. The patients were divided into 2 groups: a low-risk group (LR) comprising patients in risk classes I and II: 83 patients; a high-risk group (HR) comprising patients in risk classes III, IV and V: 63 patients; the primary endpoint of the study (MACE) was the occurrence of shock, the need for mechanical ventilation, and the occurrence of in-hospital death. total in-hospital mortality was 15.1%, significantly higher in the HR group (25.4% versus 7.2%, p=0.001). In logistic regression analysis, being in the HR group (OR=5.1; 95% CI: [1,637 - 16,093]; p=0.005)) and having renal impairment (OR=4.5; 95% CI: [1.457 - 14.075]; p=0.009) were the independent factors for the occurrence of MACE. After a mean follow-up of 18 ± 8 months, there were more deaths in the HR group (68.4% versus 33%, p=0.004). the results of our study show that the PESI score is correlated with the severity of PE. This should encourage the widespread use of this risk score.

Identifiants

pubmed: 37575526
doi: 10.11604/pamj.2023.45.48.39031
pii: PAMJ-45-48
pmc: PMC10422038
doi:

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

48

Informations de copyright

Copyright: Majed Hassine et al.

Déclaration de conflit d'intérêts

Les auteurs ne déclarent aucun conflit d´intérêts.

Références

Arch Intern Med. 2010 Aug 9;170(15):1383-9
pubmed: 20696966
Eur Heart J. 2020 Jan 21;41(4):543-603
pubmed: 31504429
N Engl J Med. 2014 Apr 10;370(15):1402-11
pubmed: 24716681
Arch Intern Med. 1999 Mar 8;159(5):445-53
pubmed: 10074952
Chest. 2015 Apr;147(4):1043-1062
pubmed: 25317677
J Thromb Haemost. 2010 Nov;8(11):2406-11
pubmed: 20626624
J Am Soc Echocardiogr. 2016 Sep;29(9):907-13
pubmed: 27427291
Semin Thromb Hemost. 2006 Nov;32(8):848-55
pubmed: 17171599
Lancet. 2011 Jul 2;378(9785):41-8
pubmed: 21703676
BMJ. 2020 Aug 5;370:m2177
pubmed: 32759284
Lancet. 1999 Apr 24;353(9162):1386-9
pubmed: 10227218
Heart Lung. 2015 Jul-Aug;44(4):327-34
pubmed: 25976228
Thromb Haemost. 2008 Nov;100(5):943-8
pubmed: 18989542
Circulation. 2006 Apr 25;113(16):2011-20
pubmed: 16636189
Anatol J Cardiol. 2021 Aug;25(8):544-554
pubmed: 34369882
J Am Heart Assoc. 2020 Sep;9(17):e016784
pubmed: 32809909
Eur Heart J Acute Cardiovasc Care. 2021 May 11;10(3):250-257
pubmed: 33620435
Eur Heart J. 2019 Mar 14;40(11):902-910
pubmed: 30590531
Chest. 2012 Apr;141(4):916-922
pubmed: 21852296
J Thromb Haemost. 2010 Jul;8(7):1509-14
pubmed: 20403093
J Thromb Haemost. 2011 Aug;9(8):1500-7
pubmed: 21645235
Circ J. 2015;79(4):889-91
pubmed: 25739720
Eur Heart J. 2006 Feb;27(4):476-81
pubmed: 16207738
Chest. 2020 Mar;157(3):636-644
pubmed: 31605702
Am J Respir Crit Care Med. 2005 Oct 15;172(8):1041-6
pubmed: 16020800
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221126173
pubmed: 36128845
Semin Thromb Hemost. 2019 Jun;45(4):321-325
pubmed: 31041801
TH Open. 2022 Oct 23;6(4):e347-e353
pubmed: 36452203
Can J Anaesth. 2007 Aug;54(8):634-41
pubmed: 17666716

Auteurs

Majed Hassine (M)

Cardiology A Department, Fattouma Bourguiba University Hospital, Cardiothrombosis Research Laboratory (LR12SP16), University of Monastir, Monastir, Tunisia.

Mohamed Yassine Kallala (MY)

Cardiology A Department, Fattouma Bourguiba University Hospital, Cardiothrombosis Research Laboratory (LR12SP16), University of Monastir, Monastir, Tunisia.

Marouen Mahjoub (M)

Cardiology A Department, Fattouma Bourguiba University Hospital, Cardiothrombosis Research Laboratory (LR12SP16), University of Monastir, Monastir, Tunisia.

Mehdi Boussaada (M)

Cardiology A Department, Fattouma Bourguiba University Hospital, Cardiothrombosis Research Laboratory (LR12SP16), University of Monastir, Monastir, Tunisia.

Nidhal Bouchahda (N)

Cardiology A Department, Fattouma Bourguiba University Hospital, Cardiothrombosis Research Laboratory (LR12SP16), University of Monastir, Monastir, Tunisia.

Habib Gamra (H)

Cardiology A Department, Fattouma Bourguiba University Hospital, Cardiothrombosis Research Laboratory (LR12SP16), University of Monastir, Monastir, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH